1. Gordon NH, Willson JKV. Using toxicity grades in the design and analysis of cancer phase I clinical trials. Statistics in Med 1992; 11: 2063–2075.
2. Von Hoff DD, Kuhn J, Clark GM. Cancer clinical trials. Methods and practice. In: Buyse ME, Sylvester RJ, eds. Design and Conduct of Phase I Trials. 1984: 210–220.
3. Marsoni S, Wittes R. Clinical development of anticancer agents- A National Cancer Insititute perspective. Cancer Treatment Rep 1984; 68–78.
4. Estey E, Hoth D, Simon R, Marsoni S, Seyland-Jones B, Wittes R. Therapeutic response in phase I trials of antineoplastic agents. Cancer Treatment Rep 1986; 70: 1105–1115.
5. Rosencweig M, Dodion P, Nicaise C, Piccart M, Kenis Y. Approach to phase I trials in cancer patients. In: Cortes-Funes H, Rozencweig M., eds. New Approaches in Cancer Therapy. New York: Raven. 1982: 1–13.